U.S. infectious disease company IPO financing 2006-2018

Amount raised through initial public offerings (IPOs) from infectious disease companies in the U.S. from 2006 to 2018 (in million U.S. dollars)*

by Matej Mikulic, last edited Sep 4, 2019
U.S. infectious disease company IPO financing 2006-2018 In 2018, R&D stage emerging infectious disease companies in the U.S. raised 111 million dollars by going public. This graph shows the amount of money companies in infectious disease in the U.S. raised through initial public offerings from 2006 to 2018, in million U.S. dollars.
Show more

Amount raised through initial public offerings (IPOs) from infectious disease companies in the U.S. from 2006 to 2018 (in million U.S. dollars)*

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.